Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Haleon PLC on Tuesday said it will add Pfizer Inc Chief Financial Officer David Denton to its board of directors from March 1.
Haleon is a Weybridge, Surrey-based consumer healthcare products company that spun off from pharmaceutical company GSK PLC in July 2022. It is 32% owned by New York-listed Pfizer and 13.5% owned by GSK.
Pfizer CFO Denton replaces John Young as non-executive director and as Pfizer representative of Haleon. John Young was Pfizer’s chief business officer until early 2022.
Haleon shares fell 1.3% to 316.70 pence each on Tuesday afternoon in London, while Pfizer shares traded 2.5% lower at $42.45 each in pre-market trading in New York.
Copyright 2023 Alliance News Ltd. All Rights Reserved.